neuroClues

Louvain-la-neuve, Belgium Founded: 2020 • Age: 6 yrs
Provider of eye-tracking devices for healthcare practitioners

About neuroClues

neuroClues is a Healthcare company based in Louvain-la-neuve (Belgium) founded in 2020 by Antoine Pouppez, Pierre Daye, and Pierre Pouget. neuroClues has raised $21.78 million across 4 funding rounds from investors including European Union, EIC Fund and Invest.BW. The company has 6 employees. Its chief executive, as recorded, is Antoine Pouppez. neuroClues offers products and services including neuroClues®. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is P³LAB.

Company details

Provider of eye-tracking devices for healthcare practitioners. The company has developed portable eye-tracking environment called Biomarkers in a Blink. It helps practitioners quantify their clinical exams instantly and empower clinicians with Biomarkers allowing them to identify Neurological Disorders.

  • Headquarters Louvain-la-neuve, Belgium
  • Employees 6
  • Founders Antoine Pouppez, Pierre Daye, Pierre Pouget
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website neuroclues.com
  • Social LinkedIn X
  • Legal Name P³lab
Key Metrics
  • Net Profit
    -$8.41 K (USD)
    98
    as on Dec 31, 2022
  • EBITDA
    $165.61 K (USD)
    149
    as on Dec 31, 2022
  • Total Equity Funding
    $21.78M (USD)

    in 4 rounds

  • Latest Funding Round
    $11.57M (USD), Series A

    Apr 2026

  • Investors
  • Employee Count
    6

Products & Services of neuroClues

neuroClues offers a comprehensive portfolio of products and services, including neuroClues®.

neuroClues®
Eye-Tracking Device

Quantifies eye movements for neurological diagnosis and monitoring.

Funding Insights of neuroClues

neuroClues has successfully raised a total of $21.78M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $11.57 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $21.78M
  • Total Rounds 4
  • Last Round Series A — $11.57M
  • First Round $4.86M

    (Nov 2021)

  • Investors Count 13

All 4 funding rounds of neuroClues with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2026$11.57MSeries A–Teampact Ventures
Apr 2024$5.36MSeries A–White Fund, European Union
Dec 2022$2.65MGrant––
Nov 2021$4.86MSeed–Invest.BW, Graph Ventures
–
Valuation history

13 investors in total: 9 institutional and 4 angel.

Investors in neuroClues

neuroClues has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Invest.BW.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Investment and financing services are provided for entrepreneurs in Walloon Brabant.
investbw.beLouvain-la-Neuve, Belgium
Early-stage venture capital funding is provided to startup founders.
graphventures.comSan Francisco, United States
A Belgian venture capital fund focused on medtech innovations is operated.
2019whitefund.beLiège, Belgium
leansquare.be
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
teampact.ventures
ec.europa.eu
wallonie-entreprendre.be

Olivier Legrain

Angel investor, ex-CEO of ION Energy, focused on cleantech and mobility
unknown_92cebf4ce48044798
Premium access

Investor details for neuroClues

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of neuroClues

3 people are tracked at neuroClues (3 in leadership); the tracked headcount is 6.

NameRoleGroup
Antoine Pouppez
Co-Founder & CEOLeadership
Pierre Daye
Co-Founder & CTOLeadership
Pierre Pouget
Co-FounderLeadership
Premium access

Complete people profiles for neuroClues

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of neuroClues

3 dated milestones of neuroClues across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded neuroClues is founded.
  2. Funding First funding round of $4.9M.
  3. Funding Latest funding round, Series A, of $11.6M.

Web traffic of neuroClues

The website of neuroClues (neuroclues.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 193.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Neuroclues

Premium access

Complete news archive for neuroClues

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about neuroClues

neuroClues was founded in 2020 and raised its 1st funding round 1 year after it was founded.

neuroClues is headquartered in Louvain-la-neuve, Belgium. It is registered at Louvain-la-neuve, Walloon Brabant, Belgium.

Antoine Pouppez is the CEO of neuroClues, as recorded in our data. They have also founded this company.

neuroClues is a funded company, having raised a total of $21.78M across 4 funding rounds to date. The company's 1st funding round was a Seed of $4.86M, raised on Nov 2021.

neuroClues has 6 employees.

Provider of eye-tracking devices for healthcare practitioners. The company has developed portable eye-tracking environment called Biomarkers in a Blink. It helps practitioners quantify their clinical exams instantly and empower clinicians with Biomarkers allowing them to identify Neurological Disorders.

neuroClues offers neuroClues®.

neuroClues has 13 investors. Key investors include European Union, EIC Fund, Invest.BW, Graph Ventures, and Olivier Legrain.

neuroClues operates through PÂłlab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available